Next generation of free? Points to consider when navigating sponsored genetic testing

Area of Science:

• Medical Genetics
• Bioethics
• Health Policy

Background:

• Genetic and genomic testing (GT) is increasingly integrated into patient care.
• High costs and access disparities limit widespread GT utilization.
• Sponsored GT, subsidized by industry, has emerged as a potential solution.

Purpose of the Study:

• To provide preliminary guidance for Canadian healthcare practitioners on sponsored GT.
• To highlight the ethical and legal considerations of industry-sponsored GT.
• To underscore the need for further research and dialogue on this topic.

Main Methods:

• This document is a preliminary guidance paper.
• It synthesizes current understanding of sponsored GT in Canada.
• It identifies key ethical, legal, and policy considerations.

Main Results:

• Sponsored GT may improve access to testing.
• Industry sponsors may gain access to patient genetic data and other sensitive information.
• The integration of sponsored GT presents challenges within Canada's publicly funded healthcare system.

Conclusions:

• Canadian healthcare practitioners need guidance when encountering sponsored GT.
• Potential conflicts of interest and data privacy issues require careful consideration.
• Urgent research and dialogue are necessary to develop comprehensive frameworks for sponsored GT.